Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Open in API
Filings indexed 2,054 across all filing types
Latest filing 2023-08-03 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Unaudited Financial and Segment wise Results of the Company (Consolidated as well as Standalone) for the quarter ended 30.06.2023 along with Limited Review Reports thereon in compliance ....
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of unaudited financial and segment-wise results for the quarter ended June 30, 2023, including consolidated and standalone financial results. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 33 and 52, which pertain to quarterly financial results. The document includes an Independent Auditor's Review Report on the unaudited consolidated financial results, which is typical for interim or quarterly reports. The presence of detailed financial data and segment-wise results confirms this is a substantive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2023-08-03 English
Unaudited Financial and Segment wise results of the Company (Consolidated as well as standalone), for the quarter ended June 30, 2023 along with Limited Review Reports thereon in Compliance ....
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of unaudited financial and segment-wise results for the quarter ended June 30, 2023, including consolidated and standalone financial results. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, specifically Regulation 33 and 52, which pertain to quarterly financial reporting. The document includes an Independent Auditor's Review Report on the unaudited consolidated financial results, which is typical for interim or quarterly reports. The presence of detailed financial data and segment-wise results confirms this is a substantive financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2023-08-03 English
Financial Result Updates
Regulatory Filings
2023-08-03 English
Schedule of Investors'' Conference Call for Dabur India Limited Q1 FY 2023-24- Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of an investors' conference call following the declaration of quarterly financial results for Q1 FY 2023-24. It includes details such as date, time, dial-in numbers, and webcast information. There are no actual financial statements or detailed analysis present. The document serves as an announcement of the conference call event rather than the call transcript itself or the financial results report. Given its brevity (2163 characters) and nature as a notification, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-07-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about the schedule of an investors' conference call for Dabur India Limited regarding their Q1 FY 2023-24 financial results. It includes details such as date, time, dial-in numbers, and webcast information. The document does not contain any financial data or analysis itself, nor is it a transcript of the call. It is an announcement informing stakeholders about the upcoming conference call. According to the filing definitions, such a document fits best under 'Call Transcript' only if it contains the full transcript, which it does not. It is also not an earnings release since it does not present financial highlights. The document is essentially a notice about the conference call, which aligns with the category 'Regulatory Filings (RNS)' as a general regulatory announcement that does not fit other categories. The document length is short (2163 characters), and it is an announcement rather than a report or transcript. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-07-18 English
Copy of Newspaper Publication
Regulatory Filings
2023-07-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.